from Today's Healthcare News -- ScienceDaily http://ift.tt/1PGPuo3
Our mission is to advice, and to make the people of the world healthier through the power of information.
Biomarker predicts which stage II colon cancer patients may benefit from chemotherapy
A biomarker has been identified that predicts which stage II colon cancer patients may benefit from adjuvant chemotherapy to prevent a disease recurrence.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1PGPuo3
from Today's Healthcare News -- ScienceDaily http://ift.tt/1PGPuo3
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment